Drug indication | DOAC type | Statistical test* | p | ||||
---|---|---|---|---|---|---|---|
Apixaban (n = 134) | Dabigatran (n = 28) | Rivaroxaban (n = 37) | |||||
Atrial fibrillation | 73 (54.5%) | 13 (46.4%) | 27 (73.0%) | ||||
Deep vein thrombosis | 34 (25.4%) | 13 (46.4%) | 8 (21.6%) | ||||
Cerebral venous thrombosis | 2 (1.5%) | 0 (0.0%) | 0 (0.0%) | 12.883 | 0.115 | ||
Pulmonary embolism | 17 (12.7%) | 1 (3.6%) | 2 (5.4%) | ||||
Others | 8 (6.0%) | 1 (3.6%) | 0 (0.0%) |